{"product_id":"cjc-1295","title":"CJC-1295-No-DAC (2mg)","description":"\u003ch3\u003ePharmacokinetics\u003c\/h3\u003e\n\u003cp\u003eCJC-1295 No DAC works especially well by the elongation of its half-life. GHRH, while achieving the same effects and results without CJC-1295, is readily discarded through the action of dipeptidyl amino peptidase IV, also known as DPP-IV.[2] In essence, regular action of GHRH is subdued by a negative feedback loop process, leading to a short half-life of roughly 7 minutes, and limited plasma and insulin production. CJC-1295 No DAC quells DPP-IV, and therefore seems to lead to heightened activity.\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eScientific Studies\u003c\/h3\u003e\n\u003cp\u003eIn one study, performed on individuals ranging from 21 to 61 years old, CJC-1295 No DAC was observed in action. Through subcutaneous injection, both weekly and biweekly, the presence of CJC-1295 pointed towards higher levels of plasma and insulin within the subjects’ blood. This was observed at dosages of 30 to 60 micrograms per kilogram of body weight.[1]\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch3\u003eSources:\u003c\/h3\u003e\n\u003cp\u003e[1] https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16352683\u003cbr\u003e\u003cbr\u003e[2] https:\/\/neobiolab.com\/research\/current-research-findings-regarding-cjc-1295\u003cbr\u003e\u003cbr\u003e[3] https:\/\/absoluterx.com\/cjc-1295\/\u003c\/p\u003e","brand":"Apex Receptor","offers":[{"title":"Default Title","offer_id":44950245409033,"sku":"62","price":12.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0719\/8402\/1769\/files\/CJC-1295-No_DAC.jpg?v=1759683085","url":"https:\/\/www.apexreceptor.com\/products\/cjc-1295","provider":"Apex Receptor","version":"1.0","type":"link"}